ANEMIA IN NEW CONGENITAL ADULT TYPE POLYCYSTIC KIDNEY MICE

被引:8
作者
KOUMEGAWA, JI
NAGANO, N
ARAI, H
WADA, M
KUSAKA, M
TAKAHASHI, H
机构
[1] KIRIN BREWERY CO LTD,PHARMACEUT LAB,3 MIYAHARA CHO,TAKASAKI,GUNMA 37012,JAPAN
[2] FUJITA HLTH UNIV,SCH MED,INST COMPREHENS MED SCI,ANIM CTR LAB,TOYOAKE,AICHI,JAPAN
关键词
ERYTHROPOIETIN; ANEMIA; KIDNEY; POLYCYSTIC;
D O I
10.1016/S0022-5347(17)38204-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Mechanisms for the development of anemia and the effects of recombinant human erythropoietin (r-HuEPO) on hematological parameters were studied in new congenital adult type polycystic kidney (DBA/2FG-pcy) mice. The majority of DBA/2FG-pcy mice showed progressive anemia and an elevation of blood urea nitrogen, while a minority showed progressive anemia following polycythemia. Kidneys with numerous cysts in the cortex and medulla occupied virtually the entire abdominal cavity, and the combined kidney weight taken as a percentage of body weight reached 13.5% in the DBA/2FG-pcy mouse. The osmotic fragility of DBA/2FG-pcy mice erythrocytes was significantly increased compared with that of normal control mice. In addition, two-fold increases in serum EPO levels, determined by radioimmunoassay, and a decreased number of colony forming unit-erythroid (CFUE) were observed in the DBA/2FG-pcy mice. The administration of r-HuEPO during anemia significantly increased the red blood cell count, hemoglobin concentration, hematocrit and reticulocyte percentage in a dose-dependent manner. These findings indicate that anemia in the DBA/2FG-pcy mouse is due to increased fragility of erythrocytes, a deficiency in EPO for the degree of anemia and a decreased number or a decreased response of erythroid progenitor cells. We suggest that the DBA/2FG-pcy mouse is a useful spontaneous model of chronic progressive renal failure.
引用
收藏
页码:1645 / 1649
页数:5
相关论文
共 23 条
  • [1] CLASSIFICATION OF RENAL CYSTS
    BERNSTEIN, J
    [J]. NEPHRON, 1973, 11 (2-4) : 91 - 100
  • [2] CANDRA M, 1985, NEPHRON, V39, P26
  • [3] DEVELOPMENT OF RADIOIMMUNOASSAYS FOR HUMAN ERYTHROPOIETIN USING RECOMBINANT ERYTHROPOIETIN AS TRACER AND IMMUNOGEN
    EGRIE, JC
    COTES, PM
    LANE, J
    DAS, REG
    TAM, RC
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 99 (02) : 235 - 241
  • [4] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL
    ESCHBACH, JW
    EGRIE, JC
    DOWNING, MR
    BROWNE, JK
    ADAMSON, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78
  • [5] HYPOGONADIA IN RABBIT - GENETIC STUDIES AND MORPHOLOGY
    FOX, RR
    CRARY, DD
    [J]. JOURNAL OF HEREDITY, 1971, 62 (03) : 163 - +
  • [6] FOX S, 1978, MOUSE NEWS LETT, V58, P47
  • [7] POLYCYSTIC KIDNEY-DISEASE - PROSPECTIVE ANALYSIS OF NONAZOTEMIC PATIENTS AND FAMILY MEMBERS
    GABOW, PA
    IKLE, DW
    HOLMES, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (02) : 238 - 247
  • [8] COIL PLANET CENTRIFUGE
    ITO, Y
    WEINSTEIN, M
    AOKI, I
    HARADA, R
    KIMURA, E
    NUNOGAKI, K
    [J]. NATURE, 1966, 212 (5066) : 985 - +
  • [9] JOSKE RA, 1956, CLIN SCI, V15, P511
  • [10] CLONING AND EXPRESSION OF THE HUMAN ERYTHROPOIETIN GENE
    LIN, FK
    SUGGS, S
    LIN, CH
    BROWNE, JK
    SMALLING, R
    EGRIE, JC
    CHEN, KK
    FOX, GM
    MARTIN, F
    STABINSKY, Z
    BADRAWI, SM
    LAI, PH
    GOLDWASSER, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (22) : 7580 - 7584